Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Tumor-Agnostic 1Thoracic 1Other hematologic neoplasm 1Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Rectal Neoplasms 1Oropharyngeal Neoplasms 1Anus Neoplasms 1

Interventions

Specimen Handling 80Fluorouracil 76Oxaliplatin 70Magnetic Resonance Spectroscopy 61Leucovorin 60Gemcitabine 56Bevacizumab 56Biopsy 41Capecitabine 40Irinotecan 38Cisplatin 37pembrolizumab 35Nivolumab 35Cetuximab 33durvalumab 30130-nm albumin-bound paclitaxel 29Paclitaxel 27atezolizumab 21Folfox protocol 20Radiotherapy 17Carboplatin 17Taxes 16dehydroftorafur 15Cyclophosphamide 15Radiation 14fludarabine 13X-Rays 13Surgical Procedures, Operative 13Albumin-Bound Paclitaxel 13trastuzumab deruxtecan 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diphenhydramine × Gastrointestinal × 30 days × Clear all
NCT04432597 2026-05-18

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
39 enrolled
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡